Brief: Oncorus Announces Research Collaboration With Daewoong Pharmaceutical
04/01/2023 12:15
Jan 4 (Reuters) - Daewoong Pharma 069620.KS :
* ONCORUS ANNOUNCES RESEARCH COLLABORATION WITH DAEWOONG
PHARMACEUTICAL FOR THE DEVELOPMENT OF LIPID NANOPARTICLE
FORMULATIONS FOR MRNA DRUG CANDIDATES
* ONCORUS -UNDER DEAL, CO & DAEWOONG TO CONDUCT JOINT
RESEARCH TO
IDENTIFY, EVALUATE FORMULATIONS OF DAEWOONG'S MRNAS ENCAPSULATED
IN CO'S PROPRIETARY LNPS
* ONCORUS INC - CO AND DAEWOONG HAVE AGREED TO COMMENCE
NEGOTIATIONS OF A POTENTIAL FUTURE LICENSE AND SUPPLY
ARRANGEMENT FOR FORMULATED PRODUCT
Source text for Eikon: ID:nGNX4ZlKW0
Further company coverage: 069620.KS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Daewoong Pharma
See all newsBrief: Daewoong Pharma Q2 Operating. Profit 77 Billion Won, Up 23% Y/Y
Brief: Daewoong Pharma Wins 92.6 Billion Won Order
Brief: Daewoong Pharma Q4 Operating Profit 45.5 Billion Won, Up 9% From Year Earlier
Brief: Daewoong Pharma Q2 Operating Profit 62.5 Billion Won, Up 26% From Year Earlier
Brief: Daewoong Pharma Q1 Operating Profit 42 Billion Won, Up 34.5% From Year Earlier